Contact this trialFirst, we need to learn more about you.
Hormone Therapy
MBX 2109 for Hypoparathyroidism
Recruiting1 awardPhase 2
Macon, Georgia
This trial aims to assess how safe and well-tolerated MBX 2109 is in patients with hypoparathyroidism who finished a 12-week treatment period in a previous study.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service